PRRX1 promotes malignant properties in human osteosarcoma

Autor: Tomoka Takao, Aki Yoshida, Daisuke Yamada, Takeshi Takarada, Eiji Nakata, Ming Lu, Tatsuo Ito, Shota Takihira, Ryoji Joko, Toshifumi Ozaki, Masahiro Nakamura, Kohei Sato, Toshiyuki Kunisada
Rok vydání: 2020
Předmět:
Zdroj: Translational Oncology
Translational Oncology, Vol 14, Iss 1, Pp 100960-(2021)
ISSN: 1936-5233
Popis: Highlights • PRRX1 is a poor-prognosis marker of human osteosarcoma. • PRRX1 promotes proliferation, invasion, and drug resistance in human osteosarcoma. • Forskolin was identified using RNA expression signatures of PRRX1 knockdown. • Forskolin decreased proliferation and migration in human osteosarcoma.
Paired related homeobox 1 (PRRX1) is a marker of limb bud mesenchymal cells, and deficiency of p53 or Rb in Prrx1-positive cells induces osteosarcoma in several mouse models. However, the regulatory roles of PRRX1 in human osteosarcoma have not been defined. In this study, we performed PRRX1 immunostaining on 35 human osteosarcoma specimens to assess the correlation between PRRX1 level and overall survival. In patients with osteosarcoma, the expression level of PRRX1 positively correlated with poor prognosis or the ratio of lung metastasis. Additionally, we found PRRX1 expression on in 143B cells, a human osteosarcoma line with a high metastatic capacity. Downregulation of PRRX1 not only suppressed proliferation and invasion but also increased the sensitivity to cisplatin and doxorubicin. When 143B cells were subcutaneously transplanted into nude mice, PRRX1 knockdown decreased tumor sizes and rates of lung metastasis. Interestingly, forskolin, a chemical compound identified by Connectivity Map analysis using RNA expression signatures during PRRX1 knockdown, decreased tumor proliferation and cell migration to the same degree as PRRX1 knockdown. These results demonstrate that PRRX1 promotes tumor malignancy in human osteosarcoma.
Databáze: OpenAIRE